secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K/A
Filed at:   2023-10-12T23:59:59+00:00
Accession:  0000313143-23-000051
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics to acquire OpSens for $2.90/share cash via arrangement
------------------------------------------------------------------

- Haemonetics to acquire all outstanding shares of OpSens via plan of arrangement under Quebec Business Corporations Act.
- Consideration of $2.90 per share in cash; termination fee of $12.075 million payable by OpSens in certain circumstances.
- Support and voting agreements with certain shareholders to vote in favor of the arrangement resolution.
- Transaction subject to shareholder approval, Quebec Superior Court order, and regulatory clearances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314323000051/0000313143-23-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314323000051/hae-20231010.htm
  HTML page:      https://secwatch.observer/filing/0000313143-23-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer